Literature DB >> 18053196

Case-cohort design in practice - experiences from the MORGAM Project.

Sangita Kulathinal1, Juha Karvanen, Olli Saarela, Kari Kuulasmaa.   

Abstract

When carefully planned and analysed, the case-cohort design is a powerful choice for follow-up studies with multiple event types of interest. While the literature is rich with analysis methods for case-cohort data, little is written about the designing of a case-cohort study. Our experiences in designing, coordinating and analysing the MORGAM case-cohort study are potentially useful for other studies with similar characteristics. The motivation for using the case-cohort design in the MORGAM genetic study is discussed and issues relevant to its planning and analysis are studied. We propose solutions for appending the earlier case-cohort selection after an extension of the follow-up period and for achieving maximum overlap between earlier designs and the case-cohort design. Approaches for statistical analysis are studied in a simulation example based on the MORGAM data.

Entities:  

Year:  2007        PMID: 18053196      PMCID: PMC2216006          DOI: 10.1186/1742-5573-4-15

Source DB:  PubMed          Journal:  Epidemiol Perspect Innov        ISSN: 1742-5573


  22 in total

1.  Computing the Cox model for case cohort designs.

Authors:  T M Therneau; H Li
Journal:  Lifetime Data Anal       Date:  1999-06       Impact factor: 1.588

2.  Comparison of case-cohort estimators based on data on premature death of adult adoptees.

Authors:  Liselotte Petersen; Thorkild I A Sørensen; Per Kragh Andersen
Journal:  Stat Med       Date:  2003-12-30       Impact factor: 2.373

3.  Sample size/power calculation for case-cohort studies.

Authors:  Jianwen Cai; Donglin Zeng
Journal:  Biometrics       Date:  2004-12       Impact factor: 2.571

4.  Estimability and estimation in case-referent studies.

Authors:  O Miettinen
Journal:  Am J Epidemiol       Date:  1976-02       Impact factor: 4.897

5.  Conditional likelihood inference in a case- cohort design: an application to haplotype analysis.

Authors:  Olli Saarela; Sangita Kulathinal
Journal:  Int J Biostat       Date:  2007       Impact factor: 0.968

6.  Nested case-control and case-cohort methods of sampling from a cohort: a critical comparison.

Authors:  B Langholz; D C Thomas
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

7.  A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer.

Authors:  Lawrence F Paszat; Katherine A Vallis; Veronique M A Benk; Patti A Groome; William J Mackillop; Andreas Wielgosz
Journal:  Radiother Oncol       Date:  2007-02-05       Impact factor: 6.280

8.  Robust variance estimation for the case-cohort design.

Authors:  W E Barlow
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

9.  Alcohol intake and cardiovascular disease and mortality: the role of pre-existing disease.

Authors:  I H M Friesema; P J Zwietering; M Y Veenstra; J A Knottnerus; H F L Garretsen; P H H M Lemmens
Journal:  J Epidemiol Community Health       Date:  2007-05       Impact factor: 3.710

10.  Occupational exposures and breast cancer among women textile workers in Shanghai.

Authors:  Roberta M Ray; Dao Li Gao; Wenjin Li; Karen J Wernli; George Astrakianakis; Noah S Seixas; Janice E Camp; E Dawn Fitzgibbons; Ziding Feng; David B Thomas; Harvey Checkoway
Journal:  Epidemiology       Date:  2007-05       Impact factor: 4.822

View more
  44 in total

1.  Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.

Authors:  Andrea Ganna; Marie Reilly; Ulf de Faire; Nancy Pedersen; Patrik Magnusson; Erik Ingelsson
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

2.  Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.

Authors:  Stephen R Cole; Michael G Hudgens; Phyllis C Tien; Kathryn Anastos; Lawrence Kingsley; Joan S Chmiel; Lisa P Jacobson
Journal:  Am J Epidemiol       Date:  2012-02-01       Impact factor: 4.897

Review 3.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

4.  Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study.

Authors:  Rolf Jorde; Henrik Schirmer; Inger Njølstad; Maja-Lisa Løchen; Ellisiv Bøgeberg Mathiesen; Elena Kamycheva; Yngve Figenschau; Guri Grimnes
Journal:  Eur J Epidemiol       Date:  2013-07-17       Impact factor: 8.082

5.  ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke Study.

Authors:  N A Zakai; S E Judd; K Alexander; L A McClure; B M Kissela; G Howard; M Cushman
Journal:  J Thromb Haemost       Date:  2014-04       Impact factor: 5.824

6.  Haemostasis biomarkers and risk of intracerebral haemorrhage in the REasons for Geographic and Racial Differences in Stroke Study.

Authors:  Neil A Zakai; Nels C Olson; Suzanne E Judd; Dawn O Kleindorfer; Brett M Kissela; George Howard; Mary Cushman
Journal:  Thromb Haemost       Date:  2017-07-06       Impact factor: 5.249

7.  Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.

Authors:  Li Jiao; Stephanie J Weinstein; Demetrius Albanes; Philip R Taylor; Barry I Graubard; Jarmo Virtamo; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Res       Date:  2011-05-03       Impact factor: 12.701

8.  Soluble receptor for advanced glycation end products and risk of liver cancer.

Authors:  Kristin A Moy; Li Jiao; Neal D Freedman; Stephanie J Weinstein; Rashmi Sinha; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

9.  The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts.

Authors:  Juha Karvanen; Kaisa Silander; Frank Kee; Laurence Tiret; Veikko Salomaa; Kari Kuulasmaa; Per-Gunnar Wiklund; Jarmo Virtamo; Olli Saarela; Claire Perret; Markus Perola; Leena Peltonen; Francois Cambien; Jeanette Erdmann; Nilesh J Samani; Heribert Schunkert; Alun Evans
Journal:  Genet Epidemiol       Date:  2009-04       Impact factor: 2.135

10.  A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.

Authors:  Robert A Scott; Daniel F Freitag; Li Li; Audrey Y Chu; Praveen Surendran; Robin Young; Niels Grarup; Alena Stancáková; Yuning Chen; Tibor V Varga; Hanieh Yaghootkar; Jian'an Luan; Jing Hua Zhao; Sara M Willems; Jennifer Wessel; Shuai Wang; Nisa Maruthur; Kyriaki Michailidou; Ailith Pirie; Sven J van der Lee; Christopher Gillson; Ali Amin Al Olama; Philippe Amouyel; Larraitz Arriola; Dominique Arveiler; Iciar Aviles-Olmos; Beverley Balkau; Aurelio Barricarte; Inês Barroso; Sara Benlloch Garcia; Joshua C Bis; Stefan Blankenberg; Michael Boehnke; Heiner Boeing; Eric Boerwinkle; Ingrid B Borecki; Jette Bork-Jensen; Sarah Bowden; Carlos Caldas; Muriel Caslake; L Adrienne Cupples; Carlos Cruchaga; Jacek Czajkowski; Marcel den Hoed; Janet A Dunn; Helena M Earl; Georg B Ehret; Ele Ferrannini; Jean Ferrieres; Thomas Foltynie; Ian Ford; Nita G Forouhi; Francesco Gianfagna; Carlos Gonzalez; Sara Grioni; Louise Hiller; Jan-Håkan Jansson; Marit E Jørgensen; J Wouter Jukema; Rudolf Kaaks; Frank Kee; Nicola D Kerrison; Timothy J Key; Jukka Kontto; Zsofia Kote-Jarai; Aldi T Kraja; Kari Kuulasmaa; Johanna Kuusisto; Allan Linneberg; Chunyu Liu; Gaëlle Marenne; Karen L Mohlke; Andrew P Morris; Kenneth Muir; Martina Müller-Nurasyid; Patricia B Munroe; Carmen Navarro; Sune F Nielsen; Peter M Nilsson; Børge G Nordestgaard; Chris J Packard; Domenico Palli; Salvatore Panico; Gina M Peloso; Markus Perola; Annette Peters; Christopher J Poole; J Ramón Quirós; Olov Rolandsson; Carlotta Sacerdote; Veikko Salomaa; María-José Sánchez; Naveed Sattar; Stephen J Sharp; Rebecca Sims; Nadia Slimani; Jennifer A Smith; Deborah J Thompson; Stella Trompet; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Jarmo Virtamo; Mark Walker; Klaudia Walter; Jean E Abraham; Laufey T Amundadottir; Jennifer L Aponte; Adam S Butterworth; Josée Dupuis; Douglas F Easton; Rosalind A Eeles; Jeanette Erdmann; Paul W Franks; Timothy M Frayling; Torben Hansen; Joanna M M Howson; Torben Jørgensen; Jaspal Kooner; Markku Laakso; Claudia Langenberg; Mark I McCarthy; James S Pankow; Oluf Pedersen; Elio Riboli; Jerome I Rotter; Danish Saleheen; Nilesh J Samani; Heribert Schunkert; Peter Vollenweider; Stephen O'Rahilly; Panos Deloukas; John Danesh; Mark O Goodarzi; Sekar Kathiresan; James B Meigs; Margaret G Ehm; Nicholas J Wareham; Dawn M Waterworth
Journal:  Sci Transl Med       Date:  2016-06-01       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.